The field of spinal muscular atrophy (SMA) treatment has been dynamically evolving, and the latest breakthrough stems from Scholar Rock's Phase 3 clinical trial of apitegromab. This experimental drug is designed to preserve muscle function, representing a potential new standard of care for SMA
BioHub Maryland recently announced a significant development in its mission to bolster the biopharma workforce within the state. Securing a $75,000 grant under the EARN Maryland program, an initiative supported by the Maryland Department of Labor, the organization will use these funds to train
The biopharmaceutical industry is a dynamic and complex sector that has seen exponential growth over recent years. Central to this growth is the practice of outsourcing various elements of the biopharma process, from raw material sourcing to finished drug development. This article delves into how
Legend Biotech is poised to enhance its cell therapy research and development capabilities with the establishment of a new R&D site in Philadelphia's Center City district. Scheduled to open by the third quarter of 2025, the 31,000-square-foot facility will employ around 55 full-time workers and be
The global biopharmaceutical characterization service market is garnering significant attention due to its transformative potential in drug development and personalized medicine. Characterization services, which include protein and peptide analysis, provide crucial data for understanding the
The pharmaceutical industry finds itself at a pivotal juncture, marked by a significant transformation in drug approvals. According to insights from the CPHI Annual Industry Survey, approvals for complex molecules are poised to surpass those for small molecules for the first time. This shift
Eli Lilly's continued advancements in pharmaceutical innovation and their commitment to escalating manufacturing capabilities encapsulate the core of the company's recent endeavors. At the heart of these developments is Eli Lilly’s extensive investment in research and development and the subsequent
Biotechnology startup Constructive Bio has recently garnered attention for its innovative advances in synthetic genomics and engineered protein translation. Winning the Innovation Award at the ELRIG Drug Discovery 2024 event highlights the transformative potential of their technologies. This
Wilson County, located in Eastern North Carolina, has recently become a hotspot for significant economic development, largely driven by substantial investments from pharmaceutical giants. Within the past eight days, the region has received promises of major funding, hinting at a promising future
In a significant development affecting the biotech industry, WuXi AppTec, a leading Chinese manufacturing company, has reported a revenue decline for the first half of 2024. This downward trend coincides with growing concerns about the impending BIOSECURE Act, which aims to restrict U.S.
